Status:
WITHDRAWN
Detecting Probable Alzheimer's Disease From Speech Using Linguistical Analysis
Lead Sponsor:
East Tennessee State University
Conditions:
Alzheimer Disease
Dementia
Eligibility:
All Genders
Brief Summary
The object of this study is to investigate the use of linguistic deficits from speech samples for the early detection of Mild Cognitive Impairment and probable Alzheimer's disease. It will also evalua...
Detailed Description
This study will investigate the use of linguistic deficits through a computational diagnostic model for the prediction of Mild Cognitive Impairment (MCI) and Probable Alzheimer's disease (PrAD) from s...
Eligibility Criteria
Inclusion
- Participants who have undergone the Mini Mental State Examination (MMSE).
- Participants who have undergone Amyloid PET scan with a diagnosis of having the Amyloid plaques or not.
- Participants with moderate or fluent English speaking ability.
Exclusion
- Participants who cannot speak as the data collection process needs to obtain speech samples.
- Participants who are severely demented or at a very late stage of Alzheimer's disease.
- Participants with stroke.
- Participants who report a history of other neurodegenerative disorders than MCI and AD.
- Participants with chronic vision impairment or who cannot see with the aid of corrective glasses.
- Participants who cannot speak English.
- A participant who have been diagnosed with HIV/AIDS as this may have a cognitive effect on its own.
Key Trial Info
Start Date :
August 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04041895
Start Date
August 13 2018
End Date
August 1 2020
Last Update
November 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
East Tennessee State University
Johnson City, Tennessee, United States, 37614